Tag Archives: news

05 November 2020. During the month of August 2020, NatuEra’s wholly-owned subsidiary in Colombia successfully completed its first export to the United Kingdom of hemp-derived CBD distillate, manufactured at its state-of-the-art, cultivation and GMP-designed extraction facility, strategically located 25 miles from Bogotá. The shipment of hemp-derived CBD distillate, conducted under a non-controlled ruling issued by Colombia’s Narcotic Control Board, is to be used for R&D purposes as part of an ongoing study to collect toxicology data on CBD and gather safety information related to NatuEra’s novel foods application process. “At NatuEra we firmly believe that the world’s hemp and cannabis-derived cannabinoid industry must be built on the cornerstone of safety and compliance. That’s why we’re committed to ensuring that our ingredients and products are safe and stable, under the highest scientific standards. The UK is one of the first countries to have set out a clear regulatory pathway for the use of CBD ingredients in…

Read more

05 November 2020. During the third quarter of 2020, NatuEra’s wholly-owned subsidiary in Colombia was awarded a total of four R&D quotas by the Colombian government to cultivate cannabis and manufacture cannabis-derived products at its fully-licensed state-of-the-art, vertically-integrated production facilities, strategically located 25 miles outside of Bogota.  The permits issued by the Ministry of Health and Social Protection and the Ministry of Justice and Law include one cultivation quota to conduct field trials and characterize psychoactive cannabis cultivars, one cultivation quota to conduct R&D related to the manufacture of psychoactive cannabis derivatives, and two R&D manufacturing quotas to analyze and characterize cannabis-derived THC bulk products. “NatuEra is fully-licensed to cultivate and manufacture psychoactive cannabis products in Colombia and we’re delighted to have been granted these R&D quotas from the Colombian government, which will allow us to evaluate and register proprietary cannabis cultivars, as well as to compile valuable data for…

Read more

March 2020. During the first and second quarters of 2020, NatuEra’s wholly-owned subsidiary in Colombia successfully completed its first exports to the United States of federally-compliant hemp-derived CBD distillate manufactured at its fully-licensed, state-of-the-art, GMP-designed cultivation and extraction facility, strategically located 25 miles from Bogota. These test exports were conducted for R&D and business development purposes under a Certificate of Non-Control issued by Colombia’s Narcotic Control Board. “The successful completion of four exports of CBD distillate to the United States over the past few months is a remarkable operational milestone for NatuEra. It speaks very highly of our team’s ability to produce and deliver CBD distillate bulk products in compliance with all applicable regulations and in conformance to world-class technical specifications. At NatuEra we know that this nascent industry is all about breaking down boundaries and it’s exciting to open up this new trade route to offer our hemp-derived bulk products in…

Read more

Bogotá, Colombia. – 12 March 2020. Less than six months after breaking ground, NatuEra successfully completed the construction of its state-of-the-art, GMP-designed cultivation, extraction and processing facilities. With over 50 guests, including all company employees, members its Board of Directors and its founders, NatuEra celebrated its official opening and the commencement of its operational and commercial activities with an event held on 12 March 2020, in which it launched its corporate culture and conducted guided tours of the facility, located less than an hour away from Bogotá’s International Airport.

Bogota, Colombia.- 11 March 2020. During the third annual general assembly of Asocolcanna, Colombia’s leading medicinal cannabis trade association, NatuEra was elected to the Board of Directors for the 2020-2022 term. Following the general assembly, NatuEra participated in a public policy discussion with Colombia’s Minister of Justice and Law, the Director of Invima (Colombia’s Food & Drug Administration) and the Director of Medicine and Health Technologies of the Ministry of Health, among other government and industry thought leaders, which focused on driving the development of the industry. See press release

Bogota, Colombia.- 02 October 2019. Following the receipt of all applicable licenses and permits, NatuEra broke ground to mark the start of the construction of its GMP-designed hemp and cannabis cultivation and extraction facilities in El Rosal, Cundinamarca. Strategically located 13 km from Bogotá, less than one hour away from El Dorado Airport, the facilities are projected to include over 270.000 square feet of cultivation area, as well as post-harvest, extraction, processing plant and administrative offices. El Rosal is located in the fertile lands of Bogotá savanna, with natural conditiond ideally suited for sustainble sungrown hemp and cannabis.

Bogota, Colombia. – 09 May 2019. In March 2019, NatuEra, The Cronos Group’s joint venture Contract Manufacturing Organization,received a license from the Colombian Ministry of Justice and Law to cultivate psychoactive cannabis for the production of seeds for cultivation, the production of grain, and the manufacture of derivative products. NatuEra intends to develop, cultivate, manufacture and export cannabis-based medical and consumer products for the Latin American and global markets. NatuEra is the cannabis industry’s first Contract Manufacturing Organization (CMO) in Latin America; it plans to allow the growing number of cannabis brands to outsource cultivation and manufacturing. NatuEra plans to develop its initial cultivation and manufacturing operations with a purpose-built, GMP-standard facility located in Cundinamarca, Colombia. See press release

Toronto, Canada. – 08 March 2019. The Cronos Group announced that the C$2.4 billion equity investment in the Company by Altria Group, Inc. (NYSE: MO) (“Altria”) has closed. Altria’s investment represents an approximate 45% ownership interest in The Cronos Group. Mike Gorenstein, The Cronos Group’s Chairman, President and Chief Executive Officer, said that this transtaction and kick-off a relationship will lead to significant growth and value creation. “Altria’s investment and the services they will provide to The Cronos Group will enhance our financial resources, and allow us to expand our product development and commercialization capabilities, and regulatory expertise to better position The Cronos Group to compete, scale and lead the rapidly growing global cannabis industry” . See press release 

Toronto, Canadá – 29 August 2018. The Cronos Group is pleased to announce that it has entered into a joint venture agreement with an affiliate of Agroidea SAS (“AGI”), Colombia’s leading agricultural services provider with over 30 years of research, development and production operations. This partnership establishes a newly formed entity -Natuera- in Colombia that will develop, cultivate, manufacture and export cannabis-based medicinal and consumer products for the Latin American and global markets. See press Release